MAP3K11 and breast cancer: The inhibition of MLK3 kinase activity by E2 was through direct phosphorylation of MLK3 by a pro-survival kinase, AKT; where Ser674 site on MLK3 was phosphorylated by E2-activated AKT, leading to ER+ breast cancer cell survival [7].